Oterus Biosystems, Inc


With over 30% of women in the US delaying childbearing past the age of 35, OTERUS BIOSYSTEMS, INC is driven to improve the efficiency of In Vitro Fertilization (IVF). Our platform technology enhances embryo implantation, aiming to increase success rates of IVF, a process often requiring multiple cycles and causing emotional and financial strain. We believe everyone, regardless of socioeconomic background, deserves a chance to build a family. Oterus Bio’s technology is an innovative approach with a reusable instrument and applicator for preparing and delivering embryos. Our technology doesn’t increase the patient’s treatment burden nor does it pose a safety risk when compared with competitors who add drugs or other invasive intra-uterine treatments. Moreover, our technology supplements genetic testing and growth tracking with an additional readout on embryo viability. Oterus Bio is transforming IVF. Contact us through our website (Oterusbio.com) for more information.